eli lilly tirzepatide trial on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 Tirzepatide Demonstrates Sustained Weight Loss

The authors found that there was an increased incidence of NAION among the patients prescribed semaglutide compared to patients with Type 2 diabetes or obesity not prescribed semaglutide

Several comments describe clinician follow-up messages appearing only after intake submission, rather than before enrollment

5 Resources for pharmacist authors who want to narrate their own audiobook Imagine this

This might explain why some people dont experience immediate results from oral supplements alone

Emergency Neurology (What Do I Do Now) (2nd ed.)

Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-Week, Randomized, Placebo-Controlled Comparison (GetGoal-L)